2015
DOI: 10.3389/fnins.2015.00173
|View full text |Cite
|
Sign up to set email alerts
|

Integrative neurobiology of metabolic diseases, neuroinflammation, and neurodegeneration

Abstract: Alzheimer's disease (AD) is a complex, multifactorial disease with a number of leading mechanisms, including neuroinflammation, processing of amyloid precursor protein (APP) to amyloid β peptide, tau protein hyperphosphorylation, relocalization, and deposition. These mechanisms are propagated by obesity, the metabolic syndrome and type-2 diabetes mellitus. Stress, sedentariness, dietary overconsumption of saturated fat and refined sugars, and circadian derangements/disturbed sleep contribute to obesity and rel… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

2
40
0
1

Year Published

2015
2015
2021
2021

Publication Types

Select...
7
3

Relationship

0
10

Authors

Journals

citations
Cited by 63 publications
(43 citation statements)
references
References 289 publications
(334 reference statements)
2
40
0
1
Order By: Relevance
“…Metabolic syndrome affects cognitive performance, including memory, executive function, processing speed, and overall intellectual capabilities [23, 4952]. The adverse effect of metabolic syndrome on cognitive function suggests that it may be associated with an increased risk of developing AD [5052]. Notably, the prevalence of metabolic syndrome is the highest among Latino adults, suggesting that it could be a risk factor that may contribute to health disparities in AD.…”
Section: Epidemiology Of Ad In the Latino Populationmentioning
confidence: 99%
“…Metabolic syndrome affects cognitive performance, including memory, executive function, processing speed, and overall intellectual capabilities [23, 4952]. The adverse effect of metabolic syndrome on cognitive function suggests that it may be associated with an increased risk of developing AD [5052]. Notably, the prevalence of metabolic syndrome is the highest among Latino adults, suggesting that it could be a risk factor that may contribute to health disparities in AD.…”
Section: Epidemiology Of Ad In the Latino Populationmentioning
confidence: 99%
“…The mechanism by which this toxicity in the brain occurs is still unknown; however, neuroinflammation, particularly priming of the brain’s resident immune cells, microglia, resulting in both detrimental and protective functions under pathological conditions, as measured by cytokine production, may underlie several cognitive and neurodegenerative disorders [16]. Additionally, chronic systemic inflammation resulting from cardiovascular disease (CVD) may be associated with an increased risk for developing neuroinflammation potentially leading to neurodegenerative disorders [17]. …”
Section: Introductionmentioning
confidence: 99%
“…Many epidemiological studies suggest that metabolic dysfunction increases the risk for Alzheimer's disease (AD) and its prodrome, mild cognitive impairment (MCI) [1,2]. Whilst the exact mechanisms are unclear, conditions such as type 2 diabetes, insulin resistance and metabolic syndrome (MetS) predict AD neuropathology in late-onset patients [3,4] and late middle-aged adults at risk for AD [5]. Despite growing interest in metabolic dysfunction and AD, the effects of MetS and related factors on cognition and especially affect are not well studied.…”
mentioning
confidence: 99%